Search Results - "Kuroiwa‐Trzmielina, Joice"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The economic costs of precision medicine for clinical translational research among children with high-risk cancer by Owens, Christopher E. L., Tan, Owen, Kuroiwa-Trzmielina, Joice, Shrestha, Rupendra N., O’Brien, Tracey, Tyrrell, Vanessa, Schofield, Deborah J.

    Published in NPJ precision oncology (05-10-2024)
    “…Embedding precision medicine in paediatric oncology shows promise to have a positive impact on how children with cancer will be treated in the future. While…”
    Get full text
    Journal Article
  2. 2

    Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: Efficacy of tributyrin, a butyric acid prodrug by KuroiwaTrzmielina, Joice, de Conti, Aline, Scolastici, Clarissa, Pereira, Douglas, Horst, Maria Aderuza, Purgatto, Eduardo, Ong, Thomas Prates, Moreno, Fernando Salvador

    Published in International journal of cancer (01-06-2009)
    “…Hepatocellular carcinoma (HCC) ranks in prevalence and mortality among top 10 cancers worldwide. Butyric acid (BA), a member of histone deacetylase inhibitors…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Abstract 60: Constitutional MGMT promoter methylation and allelic expression imbalance are associated with the c.-56C>T (rs16906252) variant by Kuroiwa-Trzmielina, Joice, Hawkins, Nicholas J., Ward, Robyn L., Hitchins, Megan P.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Loss of expression of the DNA repair protein MGMT in cancer is associated with a mutator phenotype and frequently occurs due to promoter methylation…”
    Get full text
    Journal Article
  6. 6